Archive: 24/08/2010

Study compares risk with 2 diabetes drugs

In contrast to previous reports, the risks of the composite endpoint of heart attack, heart failure, both, or death were the same - about 4 percent - for patients taking the diabetes drugs rosiglitazone or pioglitazone, according ...

dateAug 24, 2010 in Medications
shares0 comments 0